Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Total 13F shares
-
5,114,483
-
Share change
-
+3,332,096
-
Total reported value
-
$14,319,000
-
Price per share
-
$2.80
-
Number of holders
-
21
-
Value change
-
+$9,326,718
-
Number of buys
-
17
-
Number of sells
-
1
Institutional Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q1 2020
As of 31 Mar 2020,
aTYR PHARMA INC - COMMON STOCK (ATYR) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,114,483 shares.
The largest 10 holders included
FEDERATED HERMES, INC., FMR LLC, Alyeska Investment Group, L.P., VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, TWO SIGMA INVESTMENTS, LP, UBS Group AG, Ensign Peak Advisors, Inc, and TWO SIGMA ADVISERS, LP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.